Search Results for keywords:"Justice Department"

Found 164 results
Skip to main content

Search Results: keywords:"Justice Department"

  • Type:Notice
    Citation:90 FR 11553
    Reading Time:about a minute or two

    The Global Synchronizer Foundation (GSF) has filed notifications with the Attorney General and the Federal Trade Commission about changes in its membership. This action is in line with the National Cooperative Research and Production Act of 1993, which limits the recovery of damages for antitrust plaintiffs. New members joining the GSF include the Hong Kong Monetary Authority, Copper Markets (Switzerland) AG, Goldman Sachs & Co. LLC, and Bank of New York Mellon Corporation. The organization intends to continue updating its membership details to comply with the Act's requirements.

    Simple Explanation

    The Global Synchronizer Foundation is letting the government know about new members joining their group, like some big banks and companies from different countries, and this is part of rules that help make sure businesses play fair.

  • Type:Notice
    Citation:89 FR 106584
    Reading Time:about a minute or two

    Siegfried USA, LLC has submitted an application to the Drug Enforcement Administration (DEA) seeking approval to become an importer of certain controlled substances. The application is intended to allow the company to import these substances for the purpose of manufacturing bulk Active Pharmaceutical Ingredients for its customers. Interested parties, such as registered bulk manufacturers of these controlled substances, are invited to submit comments or objections to this application by January 29, 2025. Comments should be submitted electronically via the Federal eRulemaking Portal, and requests for a hearing can be sent to the DEA at the addresses provided in the document.

    Simple Explanation

    Imagine a company wants to bring special, controlled medicine ingredients into the country so they can help make important medicines. People and other companies can say what they think about this idea until the end of January next year by sending comments online.

  • Type:Proposed Rule
    Citation:86 FR 11478
    Reading Time:about a minute or two

    The Drug Enforcement Administration (DEA) of the Department of Justice is asking for public comments on proposed changes to rules about suspicious orders of controlled substances. They had initially asked for comments by January 4, 2021, but due to challenges posed by the COVID-19 pandemic, they have reopened the comment period from February 25, 2021, to March 29, 2021. The new rules would require registrants dealing with controlled substances to report any suspicious orders to a central DEA database. This change aims to improve monitoring and decision-making regarding these substances' distribution.

    Simple Explanation

    The DEA wants to hear what people think about new rules for spotting suspicious orders of certain medicines. They gave more time for people to give their thoughts because of how busy everyone has been with COVID-19.

  • Type:Notice
    Citation:90 FR 14163
    Reading Time:about 3 minutes

    The Department of Justice's Office on Violence Against Women is seeking approval from the Office of Management and Budget to extend a previously approved information collection for the Disability Grant Program. This program aims to address violence against women with disabilities by supporting grantee efforts, including training and services. They invite public comments on the information collection until April 28, 2025. Grantees, including various government and private organizations, will submit semiannual reports on their activities, estimated to take about one hour per report, resulting in a total annual burden of 36 hours.

    Simple Explanation

    The Department of Justice wants to keep getting reports about helping women with disabilities who face violence. They are asking for more time to keep doing this and want people to share their thoughts about it.

  • Type:Notice
    Citation:90 FR 10946
    Reading Time:about 3 minutes

    The Biopharmaceutical Manufacturing Preparedness Consortium (BioMaP-Consortium) submitted a notice on January 14, 2025, to the Attorney General and the Federal Trade Commission regarding changes in its membership. This action aims to ensure the Consortium's activities remain protected under the National Cooperative Research and Production Act, which limits antitrust plaintiffs' recovery to actual damages in certain cases. Several companies, including Bella Biologics and CellCo, were added as parties to the venture. The group maintains an open membership and plans further notifications for any additional changes.

    Simple Explanation

    The Biopharmaceutical Manufacturing Preparedness Consortium told the government about new companies joining their group so they can work together better on making medicine. This helps them stay protected under special rules that make it harder for others to sue them for a lot of money.

  • Type:Notice
    Citation:90 FR 11623
    Reading Time:about a minute or two

    The Stepan Company has applied to the Drug Enforcement Administration (DEA) to be registered as an importer of certain controlled substances, as per the notice from the Justice Department's DEA. The application is to import these substances to manufacture other controlled substances, but not for commercial sale in finished form. Interested parties, such as current manufacturers or applicants, can comment or request a hearing about this application until April 9, 2025. Comments and hearing requests should be submitted through specified DEA addresses or electronically via the Federal eRulemaking Portal.

    Simple Explanation

    The Stepan Company wants permission to bring in some special chemicals so they can help make other special chemicals, but not to sell them directly. People who make those special chemicals or want to can tell the big helpers (like the government) what they think about this plan until April 9, 2025.

  • Type:Notice
    Citation:86 FR 11558
    Reading Time:about a minute or two

    S&B Pharma, Inc. has applied to the Drug Enforcement Administration to be registered as a bulk manufacturer of certain controlled substances. The company intends to produce these substances in large quantities for product development and commercial sales. Specifically, S&B Pharma plans to create synthetic versions of Marihuana and Tetrahydrocannabinols. The public and current registered manufacturers have until April 26, 2021, to submit comments or request a hearing on this application.

    Simple Explanation

    S&B Pharma, Inc. wants permission from the government to make lots of special drugs called controlled substances, like fake versions of marijuana. People can tell the government what they think about this plan before April 26, 2021.

  • Type:Notice
    Citation:90 FR 8224
    Reading Time:about 4 minutes

    On November 4, 2024, The Open Group, L.L.C. (TOG) submitted notifications to the Attorney General and the Federal Trade Commission about changes to its membership, as required by the National Cooperative Research and Production Act. This filing limits antitrust plaintiffs to actual damages under certain circumstances. Several companies, including Aeronix Technologies and Booz Allen Hamilton, have joined the group, while others, such as Ball Aerospace and Teradata Corporation, have left. Additionally, Software AG changed its name to Software GmbH. The TOG group remains open to new members and plans to continue notifying authorities of any further membership changes.

    Simple Explanation

    The document talks about a group called The Open Group, which has some businesses joining and leaving. They let the government know who is in the group because it affects certain rules, but it doesn't say why some companies come or go, making it a bit confusing.

  • Type:Notice
    Citation:86 FR 130
    Reading Time:about a minute or two

    The Department of Justice announced a proposed Consent Decree filed with the U.S. District Court for the Southern District of Iowa in the case United States v. Russell Kirk, et al., addressing violations of the Clean Water Act. The defendants, including Russell Kirk and associated companies, are accused of discharging pollutants into U.S. waters without the necessary permits. The decree requires the defendants to restore affected areas, carry out mitigation measures, and pay a civil penalty. Public comments on the proposal are invited within 30 days of the notice's publication.

    Simple Explanation

    The Justice Department is asking a judge to make some people and companies fix pollution problems they caused in rivers and streams, and they also have to pay a fine. People can tell the government what they think about this plan by sending a letter within 30 days.

  • Type:Notice
    Citation:89 FR 106579
    Reading Time:about a minute or two

    Irvine Labs Inc. has applied to the Drug Enforcement Administration (DEA) for registration as a bulk manufacturer of certain controlled substances. The application aims to facilitate research and development, as well as distribution to their research customers. The public can submit comments or objections about the application until February 28, 2025, via the Federal eRulemaking Portal. This notice was officially filed and noted by the DEA on December 27, 2024.

    Simple Explanation

    Irvine Labs Inc. wants to make and sell certain special medicines, but they need permission first. People can tell the government what they think about this until the end of February next year.